Advertisement

Topics

Biosimilars Forum Applauds Senator Passage of the FDA Reauthorization Act

10:09 EDT 4 Aug 2017 | Speciality Pharma Journal

Washington, D.C. (August 3, 2017) – Today, the Biosimilars Forum issued the following statement on passage of the Food and Drug Administration Reauthorization Act (FDARA): “The Biosimilars Forum applauds Senate passage of the FDA Reauthorization Act. This legislation provides the agency with the resources it needs to effectively and efficiently review applications and ultimately enable …

Original Article: Biosimilars Forum Applauds Senator Passage of the FDA Reauthorization Act

NEXT ARTICLE

More From BioPortfolio on "Biosimilars Forum Applauds Senator Passage of the FDA Reauthorization Act"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...